Author/Creator: Scott, Frank I - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Scott, Frank I

1. 21 WHAT IS THE MOST COST-EFFECTIVE POSITION OF VEDOLIZUMAB IN THE CURRENT TREATMENT ALGORITHM OF ULCERATIVE COLITIS?. (18th January 2018)

Authors:: Scott, Frank I; Shah, Yash; Lewis, James D
Journal:: Inflammatory bowel diseases
Issue:: Volume 24(2018)Supplement 1
Page Start:: S46
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Assessing the Optimal Position for Vedolizumab in the Treatment of Ulcerative Colitis: A Simulation Model. Issue 2 (18th January 2018)

Authors:: Scott, Frank I; Shah, Yash; Lasch, Karen; Luo, Michelle; Lewis, James D
Journal:: Inflammatory bowel diseases
Issue:: Volume 24:Issue 2(2018)
Page Start:: 286
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Assessing the Optimal Position for Vedolizumab in the Treatment of Ulcerative Colitis: A Simulation Model. Issue 2 (18th January 2018)

Authors:: Scott, Frank I; Shah, Yash; Lasch, Karen; Luo, Michelle; Lewis, James D
Journal:: Inflammatory bowel diseases
Issue:: Volume 24:Issue 2(2018)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Development and Validation of an Administrative Codes Algorithm to Identify Abdominal Surgery and Bowel Obstruction in Patients With Inflammatory Bowel Disease. Issue 1 (25th February 2021)

Authors:: Gandle, Cassandra; Scott, Frank I; Waljee, Akbar; Vajravelu, Ravy K; Sansgiry, Shubhada; Hou, Jason K
Journal:: Crohn's & colitis 360
Issue:: Volume 3:Issue 1(2021)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Endoscopic and Histological Assessment, Correlation, and Relapse in Clinically Quiescent Ulcerative Colitis (MARQUEE). Issue 2 (14th March 2020)

Authors:: Osterman, Mark T; Scott, Frank I; Fogt, Franz F; Gilroy, Erin D; Parrott, Susan; Galanko, Joseph; Cross, Raymond; Moss, Alan; Herfarth, Hans H; Higgins, Peter D R
Journal:: Inflammatory bowel diseases
Issue:: Volume 27:Issue 2(2021)
Page Start:: 207
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Endoscopic and Histological Assessment, Correlation, and Relapse in Clinically Quiescent Ulcerative Colitis (MARQUEE). Issue 2 (19th January 2021)

Authors:: Osterman, Mark T; Scott, Frank I; Fogt, Franz F; Gilroy, Erin D; Parrott, Susan; Galanko, Joseph; Cross, Raymond; Moss, Alan; Herfarth, Hans H; Higgins, Peter D R
Journal:: Inflammatory bowel diseases
Issue:: Volume 27:Issue 2(2021)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Identification of the Most Cost-effective Position of Vedolizumab Among the Available Biologic Drugs for the Treatment of Ulcerative Colitis. (4th January 2020)

Authors:: Scott, Frank I; Luo, Michelle; Shah, Yash; Lasch, Karen; Vajravelu, Ravy K; Mamtani, Ronac; Fennimore, Blair; Gerich, Mark E; Lewis, James D
Journal:: Journal of Crohn's and colitis
Issue:: Volume 14:Number 5(2020)
Page Start:: 575
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Improved Quality of Life With Anti-TNF Therapy Compared With Continued Corticosteroid Utilization in Crohn's Disease. Issue 5 (11th April 2019)

Authors:: Scott, Frank I; Johnson, F Reed; Bewtra, Meenakshi; Brensinger, Colleen M; Roy, Jason A; Reed, Shelby D; Osterman, Mark T; Mamtani, Ronac; Chen, Lang; Yun, Huifeng; Xie, Fenlong; Curtis, Jeffrey R; Lewis, James D
Journal:: Inflammatory bowel diseases
Issue:: Volume 25:Issue 5(2019)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Improved Quality of Life With Anti-TNF Therapy Compared With Continued Corticosteroid Utilization in Crohn's Disease. Issue 5 (9th December 2018)

Authors:: Scott, Frank I; Johnson, F Reed; Bewtra, Meenakshi; Brensinger, Colleen M; Roy, Jason A; Reed, Shelby D; Osterman, Mark T; Mamtani, Ronac; Chen, Lang; Yun, Huifeng; Xie, Fenlong; Curtis, Jeffrey R; Lewis, James D
Journal:: Inflammatory bowel diseases
Issue:: Volume 25:Issue 5(2019)
Page Start:: 925
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor‐α‐Directed Therapy for Inflammatory Bowel Disease. (March 2018)

Authors:: Lewis, James D; Scott, Frank I; Brensinger, Colleen M; Roy, Jason A; Osterman, Mark T; Mamtani, Ronac; Bewtra, Meenakshi; Chen, Lang; Yun, Huifeng; Xie, Fenglong; Curtis, Jeffrey R
Journal:: American journal of gastroenterology
Issue:: Volume 113:Number 3(2018)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗